{"product_id":"carbapenem-resistant-enterobacteriaceae-cre-infections","title":"Carbapenem-Resistant Enterobacteriaceae (CRE) Infections","description":"\u003cp\u003eCRE infections are particularly concerning because treatment options are very limited. These bacteria have evolved mechanisms to resist many commonly used antibiotics, making infections difficult to treat and potentially life-threatening. CRE is most often seen in healthcare settings such as hospitals, nursing homes, and intensive care units, where vulnerable patients are exposed to invasive medical procedures and devices.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eTransmission of CRE occurs primarily through direct or indirect contact with contaminated surfaces, medical equipment, or infected individuals. Healthcare workers can inadvertently spread the bacteria if proper hand hygiene and infection control practices are not strictly followed. Patients with prolonged hospital stays, especially those with catheters, ventilators, or weakened immune systems, are at higher risk of acquiring CRE infections.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eCRE can cause a range of infections depending on where the bacteria spread in the body. These include urinary tract infections, bloodstream infections (sepsis), wound infections, and pneumonia. Symptoms vary accordingly but may include fever, chills, pain at the infection site, difficulty breathing, or signs of systemic illness such as confusion and low blood pressure in severe cases.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eDiagnosis of CRE infection involves laboratory testing of clinical samples such as blood, urine, or wound cultures. Specialized tests are used to identify antibiotic resistance mechanisms and confirm carbapenem resistance. Early identification is crucial for guiding appropriate treatment and implementing infection control measures to prevent further spread within healthcare facilities.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eTreatment of CRE infections is challenging and often requires the use of newer or combination antibiotics specifically active against resistant strains. Options may include drugs such as ceftazidime-avibactam, meropenem-vaborbactam, or colistin, depending on the susceptibility profile. In severe cases, supportive care in intensive care units may be necessary, along with close monitoring for complications.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003ePrevention is the most effective strategy against CRE. Strict adherence to hand hygiene, contact precautions, and environmental cleaning in healthcare settings is essential. Antibiotic stewardship programs also play a key role in reducing the unnecessary use of broad-spectrum antibiotics, which helps slow the development of resistance. Screening high-risk patients may help identify carriers and limit transmission.\u003c\/p\u003e\u003cp\u003e \u003c\/p\u003e\u003cp\u003eFor patients and families, understanding CRE infections is important because of their potential severity and limited treatment options. While these infections can be serious, careful infection control practices and early medical intervention significantly improve outcomes. Continued public health efforts and responsible antibiotic use are essential to controlling the spread of these resistant bacteria.\u003c\/p\u003e","brand":"IDB Productions","offers":[{"title":"Perfect Bound","offer_id":66868467466544,"sku":"9781776830541","price":12.0,"currency_code":"GBP","in_stock":true}],"url":"https:\/\/www.thegreatbritishbookshop.co.uk\/products\/carbapenem-resistant-enterobacteriaceae-cre-infections","provider":"The Great British Bookshop","version":"1.0","type":"link"}